On-demand education
Robotic radical prostatectomy
Management of Non-metastatic Castration Resistant Prostate Cancer (nmCRPC): Putting current evidence into practice
What treatment can be recommended in patients with local recurrence after partial nephrectomy
Dr Thomas Seisen talks about treatment options for metastatic UTUC
Management of Metastatic Kidney Cancer
PARP Inhibitor in Prostate Cancer. Part III
Outpatient programme in robot-assisted partial nephrectomy
Prof. Cornford and Dr. Briers discuss the need for patient input in the EAU Guidelines
WHO 2022 Classification of Male Genitourinary Tract tumor: What is relevant? Novelties for the practicing urologist?
New insights in treatment of bladder cancer: From localised to metastatic diseases
Advanced Prostate Cancer – Non-Metastatic Hormone-Sensitive Prostate Cancer (nmHSPC)
PARP inhibitors in prostate cancer. Part 2
Paradigm shifts in metastatic hormone sensitive prostate cancer (mHSPC): Recent treatment developments
Management of Non-metastatic Castration Resistant Prostate Cancer (nmCRPC): Putting current evidence into practice
Artificial intelligence: The role for research and patient treatment